| Financial Year |
March 31 2023 |
| Monetary Funds |
401,880,389.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,229,563.14 |
| Accounts Receivable |
1,985,846,467.88 |
| Advances to Suppliers |
62,470,044.01 |
| Other Receivables |
115,022,285.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
485,502,490.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,645,344.33 |
| Total Current Assets |
3,243,227,687.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
229,569,310.64 |
| Long-term Equity Investment |
279,486,583.59 |
| Investment Properties |
92,939,170.30 |
| Fixed Assetes |
259,081,514.67 |
| Under-construction Projects |
205,006,761.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,311,010.70 |
| R&D expenses |
-- |
| Goodwill |
158,740,564.73 |
| Long-Term Deferred and Prepaid Expenses |
3,879,028.26 |
| Deferred Income Tax Assets |
43,978,970.23 |
| Other Non-Current Assets |
1,398,440.00 |
| Sub-Total of Non-Current Assets |
1,309,112,390.26 |
| Total Assets |
4,552,340,077.71 |
| Short-Term Loans |
626,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,099,815.01 |
| Accounts Payable |
1,365,649,981.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,763,811.30 |
| Taxes Payable |
113,091,257.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
224,469,250.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
99,239,845.13 |
| Other Current Liabilities |
12,826,573.82 |
| Sub-Total of Current Liabilities |
2,641,582,387.98 |
| Long-term Loans |
61,763,595.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,751,616.23 |
| Total Liabilities |
2,708,334,004.21 |
| Paid-In Capital(Or Share Stock) |
336,368,576.00 |
| Capital Surplus |
696,205,546.52 |
| Surplus Reserve |
80,383,756.00 |
| LESS:Treasury Stock |
30,322,952.92 |
| Undistributed Profits |
697,175,181.52 |
| Minority Stockholder's Interest |
66,932,472.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,777,073,600.97 |
| Owner's Equity（Stockholder's Equity） |
1,844,006,073.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,552,340,077.71 |
